MedTrace Logo

Gabapentin in Phantom and Stump Pain

NCT00169013 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2024-08-09

No results posted yet for this study

Summary

To investigate whether gabapentin can prevent phantom and stump pain after amputation.

Conditions

  • Amputation of Lower Limb

Interventions

DRUG

Gabapentin

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Danish Pain Research Center

    lead OTHER

Principal Investigators

  • Lone Nikolajsen, MD, PhD · Danish Pain Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Completion
2006-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00169013 on ClinicalTrials.gov